Fibrobiologics Announces Preliminary Proof of Concept for Fibroblast-Based Diabetes Treatment
Fibrobiologics Announces Preliminary Proof of Concept for Fibroblast-Based Diabetes Treatment HOUSTON , March 19, 2024 /PRNewswire/ — FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”) is focused on developing therapeutics and potential, with…